Commentary: Stereotactic body radiation therapy versus surgery for stage I non-small cell lung cancer in healthy patients: Not quite there yet.
Publication
, Journal Article
Sideris, A; Onaitis, MW
Published in: JTCVS Open
March 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JTCVS Open
DOI
EISSN
2666-2736
Publication Date
March 2022
Volume
9
Start / End Page
262 / 263
Location
Netherlands
Citation
APA
Chicago
ICMJE
MLA
NLM
Sideris, A., & Onaitis, M. W. (2022). Commentary: Stereotactic body radiation therapy versus surgery for stage I non-small cell lung cancer in healthy patients: Not quite there yet. JTCVS Open, 9, 262–263. https://doi.org/10.1016/j.xjon.2021.11.011
Sideris, Antonios, and Mark W. Onaitis. “Commentary: Stereotactic body radiation therapy versus surgery for stage I non-small cell lung cancer in healthy patients: Not quite there yet.” JTCVS Open 9 (March 2022): 262–63. https://doi.org/10.1016/j.xjon.2021.11.011.
Sideris A, Onaitis MW. Commentary: Stereotactic body radiation therapy versus surgery for stage I non-small cell lung cancer in healthy patients: Not quite there yet. JTCVS Open. 2022 Mar;9:262–3.
Sideris, Antonios, and Mark W. Onaitis. “Commentary: Stereotactic body radiation therapy versus surgery for stage I non-small cell lung cancer in healthy patients: Not quite there yet.” JTCVS Open, vol. 9, Mar. 2022, pp. 262–63. Pubmed, doi:10.1016/j.xjon.2021.11.011.
Sideris A, Onaitis MW. Commentary: Stereotactic body radiation therapy versus surgery for stage I non-small cell lung cancer in healthy patients: Not quite there yet. JTCVS Open. 2022 Mar;9:262–263.
Published In
JTCVS Open
DOI
EISSN
2666-2736
Publication Date
March 2022
Volume
9
Start / End Page
262 / 263
Location
Netherlands